Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. HSCS
HSCS logo

HSCS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy HeartSciences Inc (HSCS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.610
1 Day change
-1.73%
52 Week Range
6.470
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

HeartSciences Inc (HSCS) is not a good buy for a beginner, long-term investor at this time. The technical indicators are bearish, there is no significant positive news or catalysts, and the company's financial performance shows declining EPS and negative net income. Additionally, there are no strong trading signals or influential trades to support a buy decision.

Technical Analysis

The technical indicators are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 43.208, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 2.789, with key support at 2.617 and resistance at 2.961.

Positive Catalysts

  • NULL identified. No recent news or significant trading trends from hedge funds or insiders.

Neutral/Negative Catalysts

  • Bearish technical indicators, declining EPS (-62.56% YoY), and negative net income (-$2,350,769).

Financial Performance

In Q2 2026, revenue remained flat YoY at $2,419, while net income improved slightly by 12.86% YoY but remains negative. EPS dropped significantly by -62.56% YoY, and gross margin remained flat at 58.33%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data available.

Wall Street analysts forecast HSCS stock price to rise
2 Analyst Rating
Wall Street analysts forecast HSCS stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.656
sliders
Low
9.2
Averages
10.6
High
12
Current: 2.656
sliders
Low
9.2
Averages
10.6
High
12
Ascendiant Capital
Lucas Ward
Strong Buy
Maintains
$15 → $14
AI Analysis
2025-03-18
Reason
Ascendiant Capital
Lucas Ward
Price Target
$15 → $14
AI Analysis
2025-03-18
Maintains
Strong Buy
Reason

People Also Watch